Pzena Investment Management LLC Invests $45.31 Million in Varex Imaging $VREX
Pzena Investment Management LLC has acquired a new stake of 4.34 million shares in Varex Imaging (NASDAQ:VREX), valued at approximately $45.31 million, making it a 10.32% owner of the company. Despite Varex beating earnings per share estimates, its revenue fell short, and analysts currently have a cautious "Reduce" rating with a target price below its current trading price. Several other institutional investors also adjusted their holdings in Varex Imaging during recent quarters.
Varex Imaging (NASDAQ: VREX) outlines RSU vesting and tax-share withholding for HR chief
Varex Imaging Corp's Chief Human Resources Officer, Karen L. Aranki, had 3,974 Restricted Stock Units (RSUs) vest on August 14, 2026. From these, 1,145 shares were withheld at $18.49 per share to cover tax obligations. Aranki now holds 3,975 remaining RSUs, with future vesting dates in 2026 and 2028.
Varex Imaging Corporation News | VREX Real-time News & Related Reports
This article provides an overview of Varex Imaging Corporation (VREX), including its current stock price, market capitalization, P/E ratio, and recent trading activity. It also lists various financial data points and indicates that the news and data are for reference only, not investment advice.
Rice Hall James & Associates LLC Purchases New Position in Varex Imaging $VREX
Rice Hall James & Associates LLC has acquired a new position in Varex Imaging (NASDAQ:VREX), purchasing 1.45 million shares valued at approximately $15.1 million, representing a 3.43% stake. Despite this acquisition and Varex Imaging exceeding quarterly EPS estimates, analyst sentiment remains cautious with a "Reduce" consensus rating and a target price of $16.88. Several other institutional investors also adjusted their holdings in the company during recent quarters.
Varex Imaging (NASDAQ:VREX) Receives Consensus Recommendation of "Reduce" from Brokerages
Varex Imaging (NASDAQ:VREX) has received a consensus "Reduce" rating from seven brokerages, with one sell rating and six hold ratings, and an average 12-month price target of $16.875. This comes despite recent positive institutional activity and quarterly earnings that beat consensus estimates, though revenue fell short. Several firms, including Zacks Research and Oppenheimer, have recently downgraded their ratings on the stock.
Varex Imaging (NASDAQ:VREX) Stock Rating Lowered by CJS Securities
CJS Securities downgraded Varex Imaging (NASDAQ:VREX) from an "outperform" to a "market perform" rating. This downgrade aligns with other analysts who have issued "hold" or "sell" ratings, resulting in an average "Reduce" rating and a $16.88 consensus price target for the stock. Despite exceeding Q3 EPS estimates with $0.31, revenue of $210.5 million missed the $215.5 million consensus, and the company projects full-year EPS of $0.93.
Assenagon Asset Management S.A. Sells 372,475 Shares of Varex Imaging $VREX
Assenagon Asset Management S.A. significantly reduced its stake in Varex Imaging (NASDAQ:VREX) by 80.6% in the second quarter, selling 372,475 shares and retaining 89,412 shares valued at $933,000. This move contrasts with other institutional investors like LSV Asset Management, Millennium Management, and Qube Research & Technologies, which increased their positions. Despite Varex Imaging beating EPS expectations, the stock holds a consensus "Reduce" rating and an average price target of $16.88 from analysts, indicating mixed sentiment and cautious outlook.
Varex Imaging Corporation Stock 12‑Month Price Target Cut to $17.58, Implies 42% Upside
The average 12-month price target for Varex Imaging Corporation (VREX) stock has been lowered from $18 to $17.58 by 5 analysts, with individual forecasts ranging from $12 to $20 per share. This new target suggests a potential upside of approximately 42% from its August 7 closing price. The consensus rating among the 5 covering analysts remains "Buy," comprising 2 Buys and 3 Holds.
Teledyne to Acquire Varex Imaging for $1.1 Billion in Cash, Adding Oncology X-Ray Tech
Teledyne Technologies announced its acquisition of Varex Imaging for $1.1 billion in an all-cash deal, paying $18.90 per share, a premium of over 50%. This strategic move expands Teledyne's X-ray portfolio by adding oncology-grade detectors and advanced photon-counting technology. The transaction, unanimously approved by both boards, is expected to close in early 2027, subject to regulatory and shareholder approvals.
Varex Imaging Agrees to Teledyne All-Cash Acquisition
Varex Imaging has agreed to be acquired by Teledyne Technologies in an all-cash deal valued at approximately $1.1 billion. The acquisition, pending shareholder and regulatory approvals, will result in Varex becoming a wholly-owned subsidiary of Teledyne and its delisting from Nasdaq in early 2027. This merger aims to strengthen Teledyne's position in medical imaging and industrial inspection by integrating Varex's X-ray tubes and photon-counting detectors with Teledyne's existing portfolio.
Teledyne to acquire Varex in $1.1 billion deal
Teledyne Technologies (NYSE: TDY) has announced its intent to acquire Varex Imaging Corporation (NASDAQ: VREX) for approximately $1.1 billion in cash, paying $18.90 per share. This acquisition will expand Teledyne's healthcare market presence with Varex's complementary X-ray sources and digital detectors, which are used in medical diagnostic imaging, security, and industrial applications. The transaction, unanimously approved by both boards, is expected to close in early 2027, pending regulatory and Varex stockholder approvals.
Teledyne to acquire Varex Imaging in $1.1 billion deal
Teledyne Technologies announced its agreement to acquire Varex Imaging Corporation for approximately $1.1 billion. This acquisition will significantly expand Teledyne's medical and industrial X-ray imaging portfolio by adding Varex's X-ray tubes, digital X-ray detectors, and advanced photon-counting detectors. The deal, representing an 88% premium over Varex's stock price in late May 2026, is expected to close in early 2027, pending regulatory and shareholder approvals.
Varex Imaging downgraded to Neutral from Buy at B. Riley
B. Riley downgraded Varex Imaging (VREX) to Neutral from Buy, increasing the price target slightly to $18.90 from $18.00. This change comes after Varex Imaging agreed to be acquired by Teledyne Technologies for $18.90 per share in cash, leaving limited upside potential without a competing offer.
Teledyne to acquire Varex Imaging (VREX) in $1.1B all‑cash merger deal
Teledyne Technologies will acquire Varex Imaging (VREX) in an all-cash merger deal valued at approximately $1.1 billion, including equity awards and net debt. Varex shareholders will receive $18.90 per share, and the transaction is expected to close in early 2027, subject to regulatory and stockholder approvals. The acquisition aims to complement Teledyne's existing healthcare and industrial imaging portfolio without significant product overlap.
Varex Imaging Posts Upbeat Q3 Earnings, Joins Bowman Consulting, MarineMax And Other Big Stocks Moving Hi
Varex Imaging Corp (NASDAQ: VREX) saw its shares jump 48.4% after reporting better-than-expected Q3 earnings, beating analyst estimates for EPS but missing on sales. The company also announced it would be acquired by Teledyne. Several other companies, including Bowman Consulting Group Ltd, MarineMax Inc, and AbCellera Biologics Inc, also experienced significant stock gains due to positive financial results or acquisition news.
Teledyne to Acquire Varex Imaging Corporation
Teledyne Technologies Incorporated announced it will acquire Varex Imaging Corporation for approximately $1.1 billion, or $18.90 per share in cash. This acquisition will expand Teledyne's presence in the healthcare and industrial imaging markets by integrating Varex's X-ray sources and digital detectors, which are complementary to Teledyne's existing product portfolio. The transaction, unanimously approved by both boards, is expected to close in early 2027, pending regulatory and stockholder approvals.
Teledyne to acquire Varex Imaging for $1.1 billion in cash
Teledyne Technologies Incorporated announced its definitive agreement to acquire Varex Imaging Corporation for $1.1 billion in cash, including equity awards and net debt. The deal, unanimously approved by both boards, will see Teledyne pay $18.90 per share. Varex, a developer of X-ray sources and detectors, complements Teledyne's existing healthcare market presence, with the transaction expected to close in early 2027 pending regulatory and shareholder approvals.
Varex Imaging (VREX) swings to Q3 profit with margin gains and tariff refund boost
Varex Imaging (VREX) reported a swing to profit in Q3 fiscal 2026, with GAAP net income of $15.7 million compared to a significant loss a year prior. The company saw a 4% year-over-year increase in total revenue to $210.5 million, boosted by a $17 million U.S. Customs refund for IEEPA tariffs, which enhanced gross profit. Despite a decline in cash due to debt redemption and higher inventory, non-GAAP gross margin and diluted EPS improved, reflecting stronger underlying operational performance.
Teledyne to Acquire Varex Imaging Corporation
Teledyne Technologies Incorporated announced its definitive agreement to acquire Varex Imaging Corporation for $18.90 per share in cash, valuing the transaction at approximately $1.1 billion. Both companies' boards have unanimously approved the acquisition, which is expected to close in early 2027, subject to regulatory and stockholder approvals. The acquisition aims to combine Varex's expertise in X-ray sources and detectors with Teledyne's existing healthcare market presence, offering complementary product portfolios.
VREX Looks 11.5% Undervalued on GF Value™ as It Prepares Q3 Earnings
Varex Imaging Corp (VREX) is set to release its Q3 earnings on August 10, with analysts forecasting increased EPS and revenue. Despite facing profitability and cash flow challenges, the company appears 11.5% undervalued according to GuruFocus' GF Value™ metric, though this should be interpreted cautiously due to its loss-making status. Institutional investors show a nuanced confidence, with more gurus adding than trimming positions, while insider selling indicates some management cautiousness.
Varex Imaging Corp (VREX) Stock News Today
This article provides current stock information for Varex Imaging Corp (VREX), including its latest stock price, market capitalization, and a note indicating that more news is coming soon. The stock closed at $12.410, up 1.31%, with a market cap of $523.04 million. It also lists various sections available for the stock, such as financials, stock score, and analyst ratings.
Varex Imaging Corp (VREX) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Varex Imaging Corp (VREX), highlighting its current earnings forecast score of 8.40 and ranking within the Healthcare Equipment & Supplies industry. It details analyst ratings, including an average price target of $18.00, and addresses FAQs regarding expected revenue, price targets, and past EPS performance. The article notes that most analysts recommend a "Buy" trend for VREX.
(VREX) Movement Within Algorithmic Entry Frameworks
This article provides an algorithmic analysis of Varex Imaging Corporation (NASDAQ: VREX), detailing strong near-term sentiment but neutral mid and long-term outlooks. It highlights an exceptional risk-reward setup targeting a 14.3% gain and outlines specific institutional trading strategies including long, breakout, and short positions with defined entry zones, targets, and stop losses. The analysis also presents multi-timeframe signal analysis with support and resistance levels.
Varex Imaging Corporation Revenue Breakdown – NASDAQ:VREX
Varex Imaging Corporation (VREX) generated a total revenue of $844.60 million USD last year. The Medical segment was its highest-performing, contributing $592.60 million USD, an increase from the previous year. The EMEA region was the largest contributor to revenue, accounting for $284.80 million USD.
Varex Imaging Corp (VREX) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Varex Imaging Corp (VREX), detailing its current price momentum score, support and resistance levels, and technical indicator readings. It shows that VREX has a price momentum score of 3.49 and is currently trading between resistance at 11.74 and support at 10.33, suitable for range-bound swing trading. The analysis includes a breakdown of various technical indicators and moving averages, with a summary signal of "Neutral" based on these metrics.
Varex Imaging Corp (VREX): Vanguard Capital Management discloses 5.1% ownership stake
Vanguard Capital Management LLC has disclosed a 5.1% beneficial ownership stake in Varex Imaging Corp (VREX), amounting to 2,147,586 common shares, through a Schedule 13G filing. The filing indicates that Vanguard has sole voting power over 280,424 shares and sole dispositive power over all 2,147,586 shares, with the ownership distributed across various Vanguard funds and managed accounts. No other single person holds more than a 5% interest within Vanguard's reported position.
Varex Imaging Corp (VREX) Institutional Confidence
Varex Imaging Corp (VREX) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 103.49%, showing a 6.87% increase quarter-over-quarter. Richard Pzena is the largest institutional shareholder, holding 4.15 million shares, which represents 9.52% of shares outstanding.
VREX|Varex Imaging Corp|Price:11.121|Chg%:-0.009
This analysis of Varex Imaging Corp (VREX) highlights stable fundamentals, high growth potential, and a fairly valued stock with significant institutional ownership. Analysts have rated it a "Buy" with a target price of $18.00, suggesting a 63.93% upside. The stock is currently trading sideways, making it suitable for range-bound swing trading, despite average recent market performance.
Varex Imaging Corporation Revenue Breakdown – BX:VI4
Varex Imaging Corporation (BX:VI4) generated 672.72 million CHF in revenue last year. The Medical segment was the top-performing segment, contributing 472.00 million CHF, while EMEA was the greatest regional contributor, accounting for 226.84 million CHF.
Press Release: Varex Schedules Third Quarter Fiscal Year 2026 Earnings Release and Conference Call
Varex Imaging Corporation has announced it will release its third-quarter fiscal year 2026 financial results after market close on Tuesday, August 6, 2026. This will be followed by a conference call at 5:00 p.m. ET (2:00 p.m. PT) to discuss the results and business outlook. Investors can access the live webcast or a replay through the company's investor relations website, and dial-in options are also provided.
Varex Imaging Corp (VREX) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Varex Imaging Corp (VREX), noting its current valuation score of 8.87 and its ranking within the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio, comparing it to recent highs and lows, but also states that data for P/B, P/S, and P/CF ratios have not yet been disclosed by the company.
Varex Imaging Corp (VREX) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of Varex Imaging Corp's (VREX) dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years and contains no specific dividend or stock split data. The article includes current market data for VREX.
Varex to webcast Q3 earnings call after Aug. 10 market close
Varex Imaging Corporation (Nasdaq: VREX) announced it will report its unaudited financial results for the third quarter of fiscal year 2026 after market close on Monday, August 10, 2026. A conference call and live webcast will follow the earnings release at 3:00 p.m. Mountain Time. Investors can access the webcast and replay information on the company's website and via phone.
Varex Imaging Corp (VREX) Income Statement
This article provides the quarterly and annual income statements for Varex Imaging Corp (VREX), offering detailed financial data such as total revenue, cost of revenue, operating expenses, and net income. It allows users to analyze VREX's financial performance and operational efficiency over various periods. The page also includes FAQs to help users understand how to interpret the income statement and key metrics.
VREX|Varex Imaging Corp|Price:10.920|Chg%:+0.200
Varex Imaging Corp (VREX) is a designer and manufacturer of X-ray imaging components for both medical and industrial applications. The article provides an overview of the company's segments, key executives, and shareholding information. As of Q1 2026, institutional shareholding increased, with 443 institutions holding approximately $43.57 million in VREX shares.
Varex Imaging Corp (VREX) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Varex Imaging Corp (VREX), highlighting its current earnings forecast score of 8.40 and its ranking within the Healthcare Equipment & Supplies industry. It details analyst ratings, price targets, and future EPS and revenue growth estimates for the company. The report also includes a peer comparison and answers frequently asked questions regarding VREX's financial outlook.
Varex Imaging Corporation (VI4) Q1 2025 Earnings Report - Results, Call & Slides
Varex Imaging Corporation (VI4) reported its Q1 2025 earnings, beating EPS consensus with an actual EPS of CHF0.06 against an expected CHF0.02. However, the company missed revenue expectations, reporting CHF163.65M against an expected CHF165.38M, despite a 5.16% year-over-year revenue growth. The next earnings report is estimated for August 10, 2026.
Varex Imaging Corporation (VI4) Q3 2025 Earnings Report - Results, Call & Slides
Varex Imaging Corporation (VI4) announced its Q3 2025 earnings, reporting actual EPS of CHF0.15, beating the consensus of CHF0.03, and actual revenue of CHF166.27M, exceeding the expected CHF155.88M. Despite beating estimates, the company experienced a year-over-year revenue growth decline of 2.92%. The next earnings report is estimated for August 10, 2026.
Varex Imaging Corp (VREX) Financial Health: Profitability & Balance Sheet Analysis
Varex Imaging Corp (VREX) currently holds a weak financial score of 6.92, ranking 125 out of 200 in its industry, although its operating efficiency is average. The company reported a 1.46% year-over-year increase in quarterly revenue to $216.00M, alongside a significant 217.39% year-over-year increase in net profit. However, several key financial metrics like total assets, liabilities, and free cash flow have not been disclosed by the company.
VREX|Varex Imaging Corp|Price:10.920|Chg%:+0.200
Varex Imaging Corp (VREX) is trading at $10.92, showing a 1.87% increase. The company designs and manufactures X-ray imaging components for both medical and industrial segments. Analysts currently rate VREX as a "Buy" with a target price of $18.00, indicating a significant upside potential despite the stock trading sideways in the medium term.
Varex Imaging Corporation (VREX) Q2 2025 Earnings Report - Results, Call & Slides
Varex Imaging Corporation (VREX) announced its Q2 2025 earnings, reporting an actual EPS of $0.26, beating the consensus of $0.14. The company's actual revenue was $212.90M, surpassing the expected $206.76M, marking a year-over-year revenue growth of 3.25%. The earnings call for Q2 2025 took place on May 8, 2025, and their next earnings date is estimated for August 4, 2026.
Enterprise value to revenue forward of Varex Imaging Corporation – NASDAQ:VREX
The article focuses on Varex Imaging Corporation (NASDAQ: VREX) and its enterprise value to revenue forward metric. It appears to be a stub or partial financial data entry from TradingView, indicating VREX's stock market information and offering various financial tools. While the specific value for the enterprise value to revenue forward is not provided, the article sets the context for this financial analysis.
Lobbying Update: $20,000 of VAREX IMAGING CORPORATION lobbying was just disclosed
A recent Lobbying Disclosure Act filing for Q2 2026 revealed that VAREX IMAGING CORPORATION engaged in $20,000 worth of lobbying. The lobbying efforts included discussions with House and Senate personnel regarding trade and infrastructure. Additionally, the article covers recent insider trading activity for VREX, noting one insider sale, and details significant hedge fund activity with several institutions adjusting their positions.
VREXV5053657 Bond Profile — Key Metrics
This article provides a detailed profile of the VREXV5053657 bond issued by Varex Imaging Corporation. Key metrics such as the coupon rate (7.88%), issue date (Sep 30, 2020), and maturity date (Oct 15, 2027) are highlighted. It also describes Varex Imaging Corp.'s business, which includes designing, manufacturing, and selling imaging components for both medical and industrial segments.
VREXV5963657 Bond Profile — Key Metrics
This article provides a profile of the VREXV5963657 bond issued by Varex Imaging Corporation. It details key metrics such as the coupon rate, issue and maturity dates, outstanding amount, and face value. The profile also includes a brief business description of Varex Imaging, outlining its Medical and Industrial segments.
Varex Imaging(VREX) Stock Price Today | Quotes & News
This article provides current stock price information, quotes, and news for Varex Imaging (VREX). It serves as a resource for investors interested in the company's financial performance and public announcements.
Enterprise value to revenue forward of Varex Imaging Corporation – SWB:VI4
This article provides a financial snapshot of Varex Imaging Corporation (SWB:VI4), focusing on its enterprise value to revenue forward metric. It appears to be a basic financial data point presented on a trading platform, without detailed analysis or commentary. The content primarily lists navigation and footer information from the TradingView platform.
How (VREX) Movements Inform Risk Allocation Models
The article analyzes Varex Imaging Corporation (VREX) using AI models, highlighting a strong near-term sentiment but a neutral mid and long-term outlook. It identifies an exceptional short setup with an 18.0% downside target and outlines three distinct trading strategies for different risk profiles. The analysis includes multi-timeframe signals and key support/resistance levels.
If You Invested $1,000 in Varex Imaging Corp (VREX)
This article examines the historical performance of investing $1,000 in Varex Imaging Corp (VREX) over various periods, including 1 year, 5 years, and since its trading inception in 2017. It details the company's business as a designer and manufacturer of X-ray imaging components for medical, industrial, and security markets, outlining its segments, global operations, and financial structure. The report also provides annual performance data for VREX and information about its strategic initiatives.
Price to sales forward of Varex Imaging Corporation – NASDAQ:VREX
The article provides a financial snapshot of Varex Imaging Corporation (NASDAQ: VREX) from TradingView, focusing on its price-to-sales forward metric. It appears to be a financial data page rather than a detailed analysis, offering various navigation and product links. The core content highlights the company's stock market presence and financial data availability.
